Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2008-03-20 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-BONNET-LES-OULES (42330), Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ROBESPIERRE : revenue, balance sheet and financial ratios
PHARMACIE ROBESPIERRE is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-BONNET-LES-OULES (42330),
this company of category PME
shows in 2023 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ROBESPIERRE (SIREN 503258501)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
1 790 319 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
56 236 €
24 304 €
15 808 €
93 293 €
57 124 €
72 872 €
105 978 €
132 492 €
-91 380 €
EBITDA
N/C
N/C
-35 592 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
0.9%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE ROBESPIERRE generates positive net income of 56 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
56 236 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 63%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
63.349%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
50.98%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
-74728.343
833.072
392.351
295.727
223.237
166.7
146.07
130.269
63.349
Financial autonomy
-0.104
9.202
17.004
21.291
26.37
30.447
33.16
35.689
50.98
Repayment capacity
None
None
None
None
None
None
37.603
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
0.903%
None%
None%
Sector positioning
Debt ratio
63.352025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-15 pts over 3 years
In 2025, the debt ratio of PHARMACIE ROBESPIERRE (63.35) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
50.98%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+16 pts over 3 years
In 2025, the financial autonomy of PHARMACIE ROBESPIERRE (51.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
37.6 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Watch
In 2023, the repayment capacity of PHARMACIE ROBESPIERRE (37.60) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 589.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
83.342
129.51
110.605
146.846
140.795
119.581
80.389
60.578
589.771
Interest coverage
None
None
None
None
None
None
-33.027
None
None
Sector positioning
Liquidity ratio
589.772025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent+59 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE ROBESPIERRE (589.77) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
-33.03x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE ROBESPIERRE (-33.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE ROBESPIERRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
121 455 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
25
0
0
Customer payment term (days)
0
0
0
0
0
0
2
0
0
Supplier payment term (days)
0
0
0
0
0
0
40
0
0
Positioning of PHARMACIE ROBESPIERRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE ROBESPIERRE is estimated at
893 315 €
(range 606 208€ - 1 401 735€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
606k€893k€1401k€
893 315 €Range: 606 208€ - 1 401 735€
NAF 5 année 2025
Valuation method used
Net Income Multiple
56 236 €
×
15.9x
=893 316 €
Range: 606 208€ - 1 401 735€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ROBESPIERRE with other companies in the same sector:
Frequently asked questions about PHARMACIE ROBESPIERRE
What is the revenue of PHARMACIE ROBESPIERRE ?
The revenue of PHARMACIE ROBESPIERRE in 2023 is 1.8 M€.
Is PHARMACIE ROBESPIERRE profitable?
Yes, PHARMACIE ROBESPIERRE generated a net profit of 56 k€ in 2025.
Where is the headquarters of PHARMACIE ROBESPIERRE ?
The headquarters of PHARMACIE ROBESPIERRE is located in SAINT-BONNET-LES-OULES (42330), in the department Loire.
Where to find the tax return of PHARMACIE ROBESPIERRE ?
The tax return of PHARMACIE ROBESPIERRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ROBESPIERRE operate?
PHARMACIE ROBESPIERRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart